Home Blog Page 522

Vilcek Foundation Prizes Celebrate Immigrant Musicians With $350,000 in Awards

0
Vilcek Foundation Prizes Celebrate Immigrant Musicians With 0,000 in Awards
Du Yun, Angélique Kidjo, Arooj Aftab, Juan Pablo Contreras, and Ruby Ibarra are recipients of the 2023 Vilcek Foundation Prizes in Music


The 2023 Vilcek Foundation Prizewinners in Music

A photograph of the 2023 Vilcek Foundation Prizewinners in Music: Du Yun, Ang\u00e9lique Kidjo, Arooj Aftab, Juan Pablo Contreras, and Ruby Ibarra.

NEW YORK - October 18, 2022 - (Newswire.com)

The Vilcek Foundation announces the recipients of the 2023 Vilcek Foundation Prizes in the Arts and Humanities, a part of the Vilcek Foundation Prizes Program. Awarded annually in a rotating category, the Vilcek Foundation Prizes in the Arts and Humanities recognize and celebrate immigrants' contributions to intellectual and cultural life in the United States and highlight the value of immigration for a robust society. 

In 2023, the Vilcek Foundation Prizes in the Arts and Humanities are awarded in music. The foundation is awarding five prizes, totaling $350,000 in awards. Two main prizes—the Vilcek Prizes in Music—each include a cash award of $100,000. Three additional awards—the Vilcek Prizes for Creative Promise in Music—each include a cash award of $50,000. 

The Vilcek Prizes in Music

The 2023 Vilcek Prizes in Music are awarded to Du Yun and Angélique Kidjo. Vilcek Foundation Cofounder, Vice Chair, and Secretary Marica Vilcek elaborated on the decision to award two prizes.

"With the 2023 Vilcek Prizes in Music, it was important to us to recognize a range of musicians: from those in the halls of classical music to the songwriters and performers whose music vibrates across the airwaves around the world," said Vilcek. "Music transcends language, borders, and boundaries. Du Yun and Angélique Kidjo's work exemplify this, from Du Yun's arresting operas and electrifying postmodern compositions to Kidjo's charismatic presence on the global stage over the past four decades."

Vilcek Foundation President Rick Kinsel shared similar sentiments. "The sheer scope of Du Yun's and Angélique Kidjo's work defies any easy categorization," he said. "Du Yun's virtuosic range is evidenced from her operas to her avant-garde projects like Shark in You and A Cockroach's Tarantella—her work bridges sound art and classical composition. Kidjo's prolific songwriting, albums, and collaborations have brought African music to the mainstream, while also introducing generations of listeners to Afropop, Afrobeat, and traditional West African music." He continued, "Both artists' respective influence exemplifies the broad impact immigrants have on culture and society."

Du Yun receives the Vilcek Prize in Music for her open approach to composition, which subverts the boundaries of traditional classical music by incorporating influences from punk, electronic, and experimental music, and for the virtuosity of her Pulitzer Prize-winning opera, Angel's Bone.

Born in Shanghai, China, Du Yun began studying piano at the age of four and began attending the Preparatory Divisions of the Shanghai Conservatory of Music at age six. She came to the United States to pursue higher education in music, earning her bachelor's at Oberlin Conservatory and her Ph.D. in Music Composition at Harvard University. In 2001, Du Yun co-founded the International Contemporary Ensemble with the goal of advancing the genre of experimental music through collaborations, commissions, and performances. 

Angélique Kidjo receives the Vilcek Prize in Music in recognition of her exceptional range as a singer-songwriter and for bringing African music to the global stage through her performances, albums, and collaborations. Born in Ouidah, Benin, Kidjo made her musical debut with the album Pretty in 1981. She rose to international fame in the 1990s with albums like Logozo, Ayé, and Fifa. In 1997, Kidjo immigrated to the United States, moving to Brooklyn, New York. Since then, she has continued to write, record, and tour extensively, while undertaking humanitarian work as an international Goodwill Ambassador for UNICEF and with the Batonga Foundation, which she founded in 2006. 

The Vilcek Prizes for Creative Promise in Music

The Vilcek Prizes for Creative Promise in Music are awarded to early- and mid-career immigrant musicians, composers, and music producers living and working in the United States. Recipients are selected for the professional and creative quality of their work: musical compositions and performances that represent important contributions to their genres, and that resonate and inspire both performers and audiences. 

The Vilcek Prizes for Creative Promise in Music are awarded to Arooj Aftab, Juan Pablo Contreras, and Ruby Ibarra.

Arooj Aftab receives the Vilcek Prize for Creative Promise in Music for her evocative songs and compositions that incorporate a range of influences from semi-classical Pakistani music and Urdu poetry, to jazz harmonies and experimental music. Her blend of ancient traditions and contemporary style has earned her mainstream recognition, including a 2022 Grammy nomination for Best New Artist, and a 2022 Grammy for Best Global Performance for Mohabbat. Born in Saudi Arabia to Pakistani parents, Aftab found music as an outlet for self-identification and discovery. She immigrated to the United States in 2005 to pursue studies in music composition and engineering at the Berklee College of Music. 

Juan Pablo Contreras receives the Vilcek Prize for Creative Promise in Music for his work as a composer and conductor of orchestral music that draws on his Mexican heritage, and for his leadership in founding the Orquesta Latino Mexicana. Contreras' compositions tell stories about Mexico from an immigrant perspective. A dedicated teacher and mentor, Contreras seeks to empower the next generation of musicians and to foster equity and inclusion in orchestral programming and seeks to expand classical music curriculum beyond its traditionally Eurocentric focus. Born in Guadalajara, Mexico, Contreras immigrated to the United States in 2006. He holds degrees from the California Institute of the Arts (BFA), the Manhattan School of Music (MM), and the University of Southern California (DMA). 

Ruby Ibarra receives the Vilcek Prize for Creative Promise in Music for her personal and evocative hip-hop and spoken word performances that center her experiences as a Filipina American woman, and as an immigrant growing up in the San Francisco Bay Area. Born in Tacloban City in the Philippines, Ibarra immigrated to the United States with her family in 1991. Her debut mixtape, Lost in Translation, and her 2017 album, CIRCA91, explore themes including immigration, colorism, and misogyny. In addition to her music, Ibarra is a dedicated activist, and in 2018 she founded the Pinays Rising Scholarship program. 

The Vilcek Foundation

The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation for the arts and sciences. The foundation was established in 2000 by Jan and Marica Vilcek, immigrants from the former Czechoslovakia. The mission of the foundation was inspired by the couple's respective careers in biomedical science and art history. Since 2000, the foundation has awarded over $7 million in prizes to foreign-born individuals and has supported organizations with over $5.8 million in grants.

The Vilcek Foundation is a private operating foundation, a federally tax-exempt nonprofit organization under IRS Section 501(c)(3). To learn more, please visit vilcek.org


Contact Information:
Elizabeth Boylan
Communications Manager
[email protected]
+12124722500
Related Files
VFP 2023 Press Release - Music - Newswire.pdf



Press Release Service by Newswire.com

Original Source: Vilcek Foundation Prizes Celebrate Immigrant Musicians With $350,000 in Awards

Vilcek Foundation Awards $250,000 in Prizes to Leading Immigrant Scientists

0
Vilcek Foundation Awards 0,000 in Prizes to Leading Immigrant Scientists
Alejandro Sánchez Alvarado, Edward Chouchani, Biyu J. He, and Shixin Liu are honored with the 2023 Vilcek Foundation Prizes in Biomedical Science


The 2023 Vilcek Foundation Prizewinners in Biomedical Science

A photograph of the 2023 Vilcek Foundation Prizewinners in Biomedical Science: Alejandro S\u00e1nchez Alvarado, Edward Chouchani, Biyu J. He, and Shixin Liu.

NEW YORK - October 18, 2022 - (Newswire.com)

The Vilcek Foundation has announced the recipients of the 2023 Vilcek Foundation Prizes in Biomedical Science. Awarded annually since 2006, the prizes recognize immigrant scientists at the forefront of their fields, and celebrate the importance of immigrant contributions to scientific research and discovery in the United States. In 2023, the foundation awards a total of $250,000 to Alejandro Sánchez Alvarado (b. Venezuela), Edward Chouchani (b. Canada), Biyu J. He (b. China), and Shixin Liu (b. China).

The prizes comprise the Vilcek Prize in Biomedical Science, and three Vilcek Prizes for Creative Promise in Biomedical Science. The Vilcek Prize is a $100,000 award bestowed on an immigrant scientist whose career achievements demonstrate a legacy of major accomplishment in their area of study. The Vilcek Prizes for Creative Promise are $50,000 prizes given to immigrant scientists and researchers whose early career work represents a significant contribution to their field. 

The Vilcek Prize in Biomedical Science is awarded to Alejandro Sánchez Alvarado. Edward Chouchani, Biyu J. He, and Shixin Liu receive Vilcek Prizes for Creative Promise. 

The Vilcek Prize in Biomedical Science

Alejandro Sánchez Alvarado is executive director and chief scientific officer of the Stowers Institute for Medical Research, and a Howard Hughes Medical Institute Investigator. He receives the Vilcek Prize in Biomedical Science for his contributions to the field of regeneration—from the identification of crucial genes that control regeneration in living organisms to the potential for regenerative medicine to address how we treat disease in humans. Born in Caracas, Venezuela, Sánchez Alvarado immigrated to the United States to pursue his bachelor's at Vanderbilt University before going on to complete his Ph.D. in pharmacology and cell biophysics at the University of Cincinnati School of Medicine. 

"Alejandro Sánchez Alvarado has devoted his career to understanding the fundamental molecular and cellular bases of regeneration, from the specific genes responsible for regeneration to epigenetic regulators that compel the expression of these genes," said Vilcek Foundation Chairman and CEO Jan Vilcek. "Using a freshwater flatworm—an organism called Schmidtea mediterranea—as a powerful experimental tool to study the molecular mechanisms of tissue regeneration, he has pioneered and expanded the field of regeneration. His work has broad applications for our understanding of the pathology of degenerative disease."

The Vilcek Prizes for Creative Promise in Biomedical Science

Edward Chouchani, Biyu J. He, and Shixin Liu are the recipients of the 2023 Vilcek Prizes for Creative Promise in Biomedical Science.

Edward Chouchani is an associate professor of cancer biology at the Dana-Farber Cancer Institute and an associate professor of cell biology at Harvard Medical School. He is a cofounder and board member of Matchpoint Therapeutics, a biotechnology company focused on the development of precision medicine. Born in Ottawa, Canada, Chouchani earned his bachelor's at Carleton University and his Ph.D. in biological sciences at the University of Cambridge. He receives the Vilcek Prize for Creative Promise in Biomedical Science for his work to decipher the molecular mechanisms that drive metabolic disease, with the aim of developing therapeutic interventions targeted at the molecular drivers of metabolism within cells. 

Biyu J. He is an assistant professor of neurology, neuroscience and physiology, and radiology at the NYU Grossman School of Medicine, and principal investigator of the Perception and Brain Dynamics Laboratory at NYU Langone Health. Born in Xinxiang, China, Biyu J. He immigrated to the United States to pursue her Ph.D. in neuroscience at Washington University in St. Louis. She receives the Vilcek Prize for Creative Promise in Biomedical Science for her research leadership in the field of cognitive neuroscience, and for her groundbreaking work on the biological bases of perceptual cognition and subjective experience. 

Shixin Liu receives the Vilcek Prize for Creative Promise for applying cutting-edge biophysical tools to directly visualize, manipulate, and understand the physiological function of nanometer-scale biomolecular machines including DNA replication and transcription complexes at the single-molecule level. Liu is an associate professor at The Rockefeller University, where he has been the head of the Laboratory of Nanoscale Biophysics and Biochemistry since 2016. Born in Anhui province in China, he immigrated to the United States to pursue his Ph.D. in chemistry at Harvard University.

The 2023 Vilcek Foundation Prizes

In addition to the Vilcek Foundation Prizes in Biomedical Science, in 2023 the foundation is awarding $250,000 in prizes to immigrant musicians with the Vilcek Foundation Prizes in Music. The recipients of the Vilcek Foundation Prizes in Music are Du Yun, Angélique Kidjo, Arooj Aftab, Juan Pablo Contreras, and Ruby Ibarra.

The Vilcek Foundation

The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation for the arts and sciences. The foundation was established in 2000 by Jan and Marica Vilcek, immigrants from the former Czechoslovakia. The mission of the foundation was inspired by the couple's respective careers in biomedical science and art history. Since 2000, the foundation has awarded over $7 million in prizes to foreign-born individuals and has supported organizations with over $5.8 million in grants.

The Vilcek Foundation is a private operating foundation, a federally tax-exempt nonprofit organization under IRS Section 501(c)(3). To learn more, please visit vilcek.org.


Contact Information:
Elizabeth Boylan
Communications Manager
[email protected]
+12124722500
Related Files
VFP 2023 Press Release - Biomedical Science - Newswire.pdf



Press Release Service by Newswire.com

Original Source: Vilcek Foundation Awards $250,000 in Prizes to Leading Immigrant Scientists

Amada Senior Care Partners With ZayZoon, Offering Earned Wage Access to Support Employees

0
Amada Senior Care Partners With ZayZoon, Offering Earned Wage Access to Support Employees
Amada Senior Care employees now have access to financial health with ZayZoon

PHOENIX - October 18, 2022 - (Newswire.com)

ZayZoon, the Earned Wage Access provider for small and midsized organizations, announced today a partnership with Amada Senior Care, a firm focused on enriching lives by providing nurturing, compassionate senior home care to ensure their staff has the financial flexibility they deserve. With more than 120 locations, thousands of Amada employees provide in-home care and assisted living services to seniors across 37 states.

Thirty-one Amada locations have already activated ZayZoon and more than 750 employees have signed up to have instant access to their wages as they earn them, without having to wait for their regular paycheck. In addition to ZayZoon's Wages On-Demand, Amada staff also have access to free financial education and retailer rewards, which can save customers hundreds of dollars on everyday purchases. 

"We wanted to provide our employees with a benefit that was available to everyone and desired by most. ZayZoon is a completely hands-off solution that has proven impacts on improving retention, which made offering the benefit to our staff an easy decision," said Rick Basch, COO of Amada Senior Care Franchise.

ZayZoon makes its products available to all employees, regardless of whether they are hourly or salary. In a world where there are many check-the-box benefits available that don't provide much benefit at all, it's common for a business to have 30%+ of their workforce using ZayZoon regularly. In a survey, 89% of customers reported ZayZoon had helped them in reducing their financial stress. 

About Amada Senior Care
Amada Senior Care, formerly Amada Home Care, was founded in 2007 by college friends Tafa Jefferson and Chad Fotheringham. Today, Amada Senior Care has more than 120 locations across the United States and is committed to enriching lives by providing nurturing, compassionate senior home care and by guiding families through the many senior housing options available for assisted living. Healthcare professionals and families look to Amada to help them navigate the complexities of the senior care system.

About ZayZoon

ZayZoon is on a mission to improve employee health through the use of responsible financial products. Unfortunately, millions of Americans rely on predatory products such as payday loans and overdraft fees to bridge the paycheck-to-paycheck gap created by pre-determined payroll cycles. With their products, including Wages On-Demand, Financial Education and retail rewards, ZayZoon helps break that cycle. ZayZoon's on-demand access to wages helps reduce financial stress and improve workplace satisfaction and productivity.


Contact Information:
Shannon Dougall
Senior Vice President, Marketing
[email protected]


Press Release Service by Newswire.com

Original Source: Amada Senior Care Partners With ZayZoon, Offering Earned Wage Access to Support Employees

TVAX Biomedical Announces Receipt of $2 Million FDA Orphan Products Grant for Glioblastoma Study

0
TVAX Biomedical Announces Receipt of  Million FDA Orphan Products Grant for Glioblastoma Study
OLATHE, Kan. - October 18, 2022 - (Newswire.com)

TVAX Biomedical (TVAX) is a cancer immunotherapy company that is moving into its pivotal glioblastoma study for FDA regulatory approval. In September 2022, TVAX Biomedical received an approximately $2 million 4-year grant from the FDA Office of Orphan Products for its planned glioblastoma study. TVAX Immunotherapy® could fundamentally change the way cancer is treated as T cells can kill all cancer cells, including cancer stem cells, without the toxicity of current treatments. TVAX Biomedical has previously received Fast Track Designation and Orphan Product Designation from the FDA. Dr. Wayne Carter, TVAX Biomedical CEO exclaimed, "We are thrilled to receive this highly competitive grant from the FDA and eager to bring this novel therapy to glioblastoma patients looking for better options!"

TVAX Immunotherapy is a cutting-edge approach to cellular therapy. The individualized therapy first helps the patient develop immunity against their cancer and the unique "neoantigens" that cancer cells produce.  Next, T cells are removed from patient's blood and activated in TVAX's specialized manufacturing facility. Patients are then treated with billions of their own "killer" T cells that attack their cancer. Dr. Wayne Carter, TVAX Biomedical's CEO, explains it like this: "TVAX's technology uses 'killer' T cells that function like billions of smart bombs hunting and destroying cancer cells throughout the body. TVAX Immunotherapy has very few side effects because 'killer' T cells kill cancer cells, not normal cells."

This therapy has shown promising results for four-legged friends too. The ability to treat multiple types of cancer prompted TVAX to spin-off its animal health division into Elias Animal Health, an affiliate pursuing similar treatments in dogs. Elias is using the technology to treat osteosarcoma, an incurable bone cancer and is completing their registration study with the USDA.

TVAX Immunotherapy has been administered to more than 120 patients and has demonstrated efficacy against several cancers, producing numerous long-lasting complete and partial responses with none of the "off-target" short and long-term toxicity seen with CAR-T cell therapy, checkpoint inhibitors, and chemotherapies. 

FDA Fast Track Designation affords many advantages, including a pathway to accelerated marketing approval.  TVAX Immunotherapy has dramatically lower manufacturing costs compared to other cellular immunotherapies such as CAR-T therapies.

About TVAX Biomedical

TVAX Biomedical is a clinical stage development company advancing its proprietary personalized T cell-based cancer immunotherapy. The company's lead candidate is supported by positive Phase 2 clinical data, as well as extensive preclinical and Phase 1 safety studies. TVAX plans to initiate a registration study in newly diagnosed glioblastoma patients in 2023. The US brain cancer market is $1.5 billion with many follow-on market opportunities in other types of cancer. As part of its ongoing strategy, the company is seeking investors and corporate alliances to support the development.

For more information please contact[email protected]; 913-492-2221

###


Contact Information:
General Info
Marketing
[email protected]
913-492-2221


Press Release Service by Newswire.com

Original Source: TVAX Biomedical Announces Receipt of $2 Million FDA Orphan Products Grant for Glioblastoma Study

Nedap to Partner With PUMA North America for RFID Roll Out

0
Nedap to Partner With PUMA North America for RFID Roll Out
GROENLO, The Netherlands - October 18, 2022 - (Newswire.com)

Nedap (AMS:NEDAP), the global leader in RFID solutions, has been selected by PUMA North America to roll-out Nedap's iD Cloud inventory visibility platform.

Following the success of Nedap's three-store pre-rollout, 135 of PUMA stores in North America are now being equipped with Nedap's iD Cloud, allowing fast and regular stock counts, efficient replenishment, smart refill suggestions and data-driven loss prevention. The store solution also enables stores to always have the right products available and, as such, to provide best-in-class omnichannel customer experiences. And with better stock visibility, PUMA NA can offer services such as Ship-From-Store and Click & Collect (BOPIS) more efficiently.

''The partnership with Nedap will ensure PUMA North America is able to further accelerate the flexibility and the service portfolio of its omnichannel business,'' explains Russ Kahn, Sr. Vice President, North America Retail at PUMA. ''RFID technology is already creating a seamless brand experience for PUMA NA across all consumer touchpoints, with stock visibility a key enabler for product availability as well as circular services, which has allowed PUMA NA to achieve 2% uplift in replenishment and 2% uplift in sales.''

A collaborative partnership

PUMA North America selected Nedap iD Cloud due to its ease of adoption for PUMA NA stores and iD Cloud's platform capabilities. Since the selection of the platform, PUMA NA has rolled-out iD Cloud's Store with the full deployment paid back within six months. The next step is to implement Nedap's loss prevention technology.

''PUMA aims to be the fastest sports brand in the world, and we are excited to be a part of their journey as PUMA's North American RFID partner," comments Wouter Ubbels, Vice President of Sales Retail, North America at Nedap. "Our partnership with PUMA NA has been collaborative and we were able to generate exceptional value with minimal complexity, which they were not achieving prior to introducing iD Cloud. Our future-proof solution was fast to be adopted in stores and has quickly become a vital part of everyday operations."

More information about Nedap iD Cloud.


Contact Information:
Ilse Protsman
Marketing Communications Manager Retail
[email protected]
+31655415167
Related Files
PUMA selects Nedap for North American RFID roll-out_final.pdf



Press Release Service by Newswire.com

Original Source: Nedap to Partner With PUMA North America for RFID Roll Out

Visited Releases List of Top 10 Most Popular Ancient Sites

0
Visited Releases List of Top 10 Most Popular Ancient Sites
Travel App Visited Compiles Users' Data to Determine the Most Visited Ancient Sites in the World

TORONTO - October 18, 2022 - (Newswire.com)

The travel app Visited by Arriving In High Heels Corporation has published a list of the top 10 most popular ancient sites that international travelers visit. 

Visited, available on iOS or Android, is a top app for international travelers. The travel app allows users to check off places they've been, see custom maps of their travels, discover new destinations, get custom-printed travel maps, and set travel goals. 

The top 10 most visited ancient sites include:

  1. The Colosseum in Rome, Italy is the largest amphitheater in the world and one of the oldest, dating back to A.D. 70. The famed Roman gladiator battles took place in the iconic circular arena. 
  2. The Acropolis, in Greece, is an ancient citadel that includes historic masterpieces like the Parthenon overlooking the city of Athens. 
  3. Pompeii, Italy, draws tourists seeking stunningly detailed glimpses of the past, with the well-preserved ancient city of Pompeii that was buried by a volcano in AD 79. 
  4. Stonehenge, England is a prehistoric monument that dates back 5,000 years and includes construction from the Neolithic age. 
  5. Athenian Agora, Greece brings to life the ancient Greek agora, or public gathering place, with remaining temples and beautiful ancient architecture. 
  6. Chichen Itza, Mexico is a complex containing ancient Mayan ruins, including an expansive step pyramid. 
  7. The Great Pyramid at Giza is the largest Egyptian pyramid and the oldest of the Seven Wonders of the Ancient World. 
  8. Machu Picchu, Peru is an Incan citadel dating back to the 15th century. 
  9. Tulum, Mexico is home to some of the best preserved ancient Mayan ruins, with remains of a walled city.
  10. Roman Baths in the city of Bath, Somerset, England, feature an ancient Roman bathing complex and temple with hot springs that still run today. 

To see the full list of the most visited ancient sites and over 50 lists of the most popular travel destinations in the world, download Visited on iOS or Android

To learn more about the Visited app, visit https://visitedapp.com

About Arriving In High Heels Corporation

Arriving In High Heels Corporation is a mobile app company with apps including Pay Off DebtX-Walk, and Visited, their most popular app. 

Contact Information

Anna Kayfitz

[email protected]


Contact Information:
Anna Kayfitz
CEO
[email protected]


Press Release Service by Newswire.com

Original Source: Visited Releases List of Top 10 Most Popular Ancient Sites

Optimus Launches Treasury Management Solutions

0
Optimus Launches Treasury Management Solutions
Consulting and recruiting firm builds on existing capabilities with a unique team of experts in the Treasury management systems space.

HOUSTON - October 18, 2022 - (Newswire.com)

When an organization needs to improve its financial management and make faster decisions, it looks to automate processes and reduce margin of error more efficiently. Doing this successfully requires people who know finance and technology, and most importantly, people fluent in both. Recognizing that need, Optimus, a provider of strategic consulting and recruiting services, has launched a division specializing in Treasury transformation.

Houston-based Optimus, founded in March 2004 by energy industry veterans, has deep experience in the recruiting and solutions space, particularly in the commodities and technology sectors. "Coming from the business and having direct experience in the business processes and systems leveraged by our clients has been a consistent recipe for success," said Michelle Bruce, Partner at Optimus. "Adding a strong team of experts who can do the same in the treasury space just makes sense."

As management of cash flow becomes increasingly critical and complex, Treasury Management Systems (TMS) have emerged as a crucial element for organizations across industries. Transitioning from processes that are partly or largely manual is an enormous challenge. Businesses now realize the need for automated systems and see that strategic planning for that change is vital in order to implement an effective system that includes an appropriate integration architecture. Without proper planning, companies can expect day-to-day operations to be severely affected and costs to rise exponentially.

"The most successful businesses can manage, invest, and forecast optimally and proactively through turbulent market conditions," Bruce said. "Businesses want to create efficiencies with automation that streamline day-to-day operations, allowing for employee focus on strategic thinking and data analytics as opposed to cumbersome process steps." 

Optimus leaders see the Treasury Division as a natural expansion of its success in delivering energy and commodities trading risk management (ETRM/CTRM) solutions. The team of Treasury experts possesses the rare experience of having worked in both financial consulting as well as within technology vendors.

"Optimus team members have been on both sides of the equation and have a true understanding of what it takes to implement a TMS solution," said Darren Hartzell, Managing Director at Optimus. "With our level of vendor knowledge, we excel as the intermediary between the client and the vendor. Our ability to be that translator is unique in the consulting sector. Having worked on both the technical and functional sides, we can provide much more strategic insight for the client."

The Optimus Treasury Division also leverages the firm's well-established Human Capital solutions in its approach. Implementing a TMS program can require hiring temporary or permanent staff to ensure success and to foster the organization's independence and long-term growth.

"We want to empower the business teams, ensuring they have the knowledge they need to be comfortable and confident in what they do every day," said Heather Leverett, Partner at Optimus. "Our goal is to come in, be efficient and effective, and deliver the solution the client needs for long-term success." 

To learn more about Optimus' consulting solutions, please visit https://optimus-us.com.

About Optimus

Optimus is a global provider of human capital integrated solutions and consulting services, offering experienced strategic consulting, direct hire placement and specialized staffing services. Founded in March 2004 by energy industry veterans, Optimus has built a substantial team of seasoned professionals with deep experience in the recruiting and solutions space, and a particular emphasis on the commodities, financial, and technology business areas. The firm's direct and extensive experience in the business areas it serves whether Commodities Trading & Marketing or Treasury sets Optimus apart from the competition.

We are People. Solutions. Delivered.


Contact Information:
Jessica Lombao
[email protected]


Press Release Service by Newswire.com

Original Source: Optimus Launches Treasury Management Solutions

TSOLife Closes Series A Funding to Provide Senior Living Operators More Advanced Decision-Making Tools

0
TSOLife Closes Series A Funding to Provide Senior Living Operators More Advanced Decision-Making Tools
TAMPA, Fla. - October 18, 2022 - (Newswire.com)

TSOLifeInc., the only AI-based business intelligence platform that translates resident intake data into actionable insights that help communities create individualized experiences, announced today that it completed a $9 million Series A funding round. Arnie Whitman, a long-time venture investor in senior care and technology, Executive Chairman at Formation Capital and Founding Partner at Generator Ventures led the round to help accelerate the development of TSOLife's next-generation Minerva platform. Omega Healthcare Investors, Inc. and Ziegler Link-age Fund III joined the round as well.  

TSOLife has already achieved significant milestones, partnering with some of the largest operators in the industry. "The pandemic fueled the understanding that engagement and resident experience is vital to the physical and mental health of residents and the success of a community," said David Sawyer, the Founder and Chief Executive Officer of TSOLife. "This funding round will accelerate our ability to enhance the lives of seniors by leveraging data to provide robust resident insight technology unique to TSOLife. We have a passion for bringing state-of-the-art-tech to the market, while never forgetting that our goal is to improve the lives of residents and staff."  

TSOLife Minerva is the first-of-its kind business intelligence platform that uses Artificial Intelligence (AI) to transcribe resident interviews and automatically convert the information into organized, consumable data. This person-centered data fuels powerful dashboards providing staff with personal, actionable insights and saves valuable staff time.  

"TSOLife improves staff efficiency not by demanding more, but by eliminating time-consuming tasks, which is a win-win for providers," said Katie Schmitz, Chief Administrative Officer of the Ziegler Link-age Fund III. "The platform allows staff to spend more time doing what they love - engaging with residents!" The next generation of the Minerva platform will leverage care-level-specific engagement data to help increasingly tech-savvy seniors self-select their own experience and take more control of their overall health and well-being.

"TSO is the tip of the spear in gathering social insights to improve quality of life and relationships in a unique and powerful way," said Arnie Whitman, lead investor. "Data and AI will allow for more personalization and better social and health outcomes. Everyone talks about social determinants; TSO actually measures it!" Visit www.tsolife.com for more information.

About TSOLife, Inc.

TSOLife partners with senior living communities across the nation to provide a first-of-its-kind business intelligence platform using Artificial Intelligence (AI) called Minerva. Minerva creates powerful dashboards with a suite of information and personalized tools for staff to put prospect and resident knowledge into practice. TSOLife provides actionable insights and fuels decision-making in senior living communities. Visit www.tsolife.com for more information.

About Omega Healthcare Investors, Inc.

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the United Kingdom.

About Ziegler Link-Age Fund III, LP

Ziegler Link-Age Fund III is the third fund managed by a joint venture between Ziegler (www.ziegler.com) and Link-Age (www.LinkageConnect.com) that seeks to support emerging companies operating in or developing businesses focused on aging and related care. The Fund's investments align with the goals of its limited partner investors who consist primarily of organizations across the senior living and care, healthcare, and aging services landscape that have a significant interest in finding innovative solutions to improve the independence, quality and cost of care, and overall lives of the aging population.


Contact Information:
Lauren Wilson
VP Sales and Marketing
[email protected]
503-887-1353


Press Release Service by Newswire.com

Original Source: TSOLife Closes Series A Funding to Provide Senior Living Operators More Advanced Decision-Making Tools

Patients Choice Laboratories Acquires Infinity Laboratories, LLC to Better Provide Complete Suite of Services to Providers in the Southern U.S.

0
Patients Choice Laboratories Acquires Infinity Laboratories, LLC to Better Provide Complete Suite of Services to Providers in the Southern U.S.
INDIANAPOLIS - October 18, 2022 - (Newswire.com)

Patients Choice Laboratories (PCL), a leading provider of comprehensive laboratory testing throughout the U.S., announced today that it has acquired Infinity Laboratories, LLC located in Bridgeport, TX. Infinity Laboratories is an infectious disease laboratory specializing in molecular diagnostics serving the population of north Texas. The acquisition will provide PCL a location in the southern United States to bring their complete suite of testing services to the area for providers and patients. 

PCL specializes in infectious disease, pharmacogenetics, blood work and toxicology. Utilizing industry-leading molecular diagnostics, PCL provides precise and specific results allowing for quick diagnoses and treatment of patients within 24-hours.

"Having already performed laboratory services for Texans for many years, we are looking forward to teaming up with the Texas healthcare community as a local laboratory," said Brad Moss, President of PCL. "We have a proud history of assisting providers in accelerating their decision-making process for treatment, providing the fastest turnaround times in the lab industry, and working with some of the leading health systems and providers in the nation. Our plan is to introduce our complete suite of services to area providers so that they can work with one laboratory to service all their diagnostics needs."

Using innovative molecular diagnostics, PCL provides custom treatment recommendations based on antibiotic-resistant genes found in infections. These recommendations improve antimicrobial stewardship, patient outcomes, and reduce healthcare costs.

Additionally, with their Pharmacogenetics testing, PCL plans to place focus on increased treatment success and lowering cash spending for patients. According to data from Kaiser Family Foundation, Texas has the highest level of cash spending on retail prescription drugs with an annual state total of over $900 million. "Texas is committed to ensuring patients have access to medications, and research has shown our genetic testing can help treatment success and lower cash spending by ensuring patients are on the correct medication and dosage. This test will serve as a platform for patients and providers to optimize medication management," said Moss. 

Patients Choice Laboratories plans to begin running tests out of their newly acquired Bridgeport, Texas location in the coming weeks.

About Patients Choice Laboratories 

Patients Choice Laboratories (PCL), a CLIA certified and CAP accredited laboratory based in Indianapolis, Indiana, is a leading provider of comprehensive laboratory testing throughout the United States. Since 2013 PCL has served patients and providers with a focus on fast, accurate, and reliable results. Utilizing innovative molecular technology, PCL provides specific results allowing for quick diagnoses and treatment of patients. PCL can provide treatment recommendations based on antibiotic-resistant genes to improve antimicrobial stewardship and patient outcomes. 

PCL is at the forefront of infectious diseases, pharmacogenetics, and toxicology to ensure the health of our communities now and into the future. Learn more about how we are pioneering new ways to provide patient care on our website: pclabsdx.com.


Contact Information:
Tyler McKee
Marketing
[email protected]
833-569-0440


Press Release Service by Newswire.com

Original Source: Patients Choice Laboratories Acquires Infinity Laboratories, LLC to Better Provide Complete Suite of Services to Providers in the Southern U.S.

What Refinancing Means for You

0
What Refinancing Means for You
NEW YORK - October 18, 2022 - (Newswire.com)

iQuanti: You don't have to be stuck in a bad loan forever. When you refinance a car loan or other types of loans, you trade in your existing loan for one with better terms. 

Refinancing: the basics

Refinancing is the process of applying for a new loan to secure a lower interest rate or extend your repayment schedule. When you're approved for the new loan, your lender will pay off your existing loan, and the old loan account will be closed. 

When is refinancing a good idea?

Refinancing is beneficial in many situations. For example: 

  • You can't afford your current payments: If you're struggling to keep up with your monthly loan payments, refinancing into a loan with a longer repayment term can help get you back on track. However, a longer term could lead to a higher overall cost due to interest.
  • Interest rates are lower: A good time to consider refinancing is when interest rates have fallen. If interest rates are lower than when you got your current loan, refinancing can get you into a better rate, saving you money over the life of your loan. 
  • You have a better credit score: If you have a better credit score than when you applied for your current loan, refinancing might help you secure better terms. A higher credit score could translate to a lower interest rate and lower monthly payments.
  • You have a variable loan: The interest rate on a variable loan fluctuates during the life of your loan. Many people prefer the predictability of fixed loans since the interest rate remains unchanged for the entire duration of the loan.

Should you refinance?

If it gets you into a more affordable loan with a lower rate and better terms, refinancing can be wise if it helps you avoid missing payments, which can severely impact your credit score and financial stability. Though you might see a ding on your credit score after refinancing, it's preferable to a late payment that can remain on your credit for several years. 


Contact Information:
Keyonda Goosby
Public Relations Specialist
[email protected]
(201) 633-2125

Carolina Darbelles
Senior Public Relations Specialist
[email protected]
(201) 633-2125


Press Release Service by Newswire.com

Original Source: What Refinancing Means for You